Abstract
The PSMA is a specific prostatic membrane antigen (glycoprotein type 2) found in the membrane or cytoplasm of the Prostate Cancer cell and has been targeted for treatment of this disease. The discovery of PSMA allowed the creation of novel substances that bind specifically to the antigen and results into more efficient therapies for non-responsive cases, especially of cancer that is not r…